Netlist Inc (NASDAQ: NLST) on Tuesday reported a first-quarter loss of $0.03 per share, 3 cents narrower than the prior-year loss, and in line with the Wall Street estimate. Net sales for the quarter fell 42% to $5.1 million, missing the consensus view of $8 million.
NLST shares ended its last trading session up 3.4 % on Tuesday. In the trailing 52 weeks, the stock has gained 135%.
CEO C.K. Hong said, “The results reflect the positive impact of ongoing cost management, which partially compensated for the short-term softness in revenue related to the global erosion in the pricing of server DRAM.
The memory products maker said its gross profit for the quarter ended March 30, 2019, was 5.5% of net sales, compared to 4.3% of net sales for the quarter ended March 31, 2018.
Last month, rival Rambus (NASDAQ: RMBS) reported a loss of 8 cents per share in the first quarter of 2019, even as analysts were expecting earnings of 23 cents per share. Investors sent the stock down over 13% immediately following the disappointing earnings announcement.
READ: THE CANNABIS-BEVERAGE INDUSTRY IS SOMETHING YOU DON’T WANT TO MISS THIS YEAR
Netlist offers Hybri dual in-line memory module (DIMM), a storage class memory product, which unifies dynamic random access memory (DRAM) and NAND flash, delivering terabyte storage capacities operating at nanosecond memory speeds.
Most Popular
Microsoft (MSFT) reports higher revenue and profit for Q3 2024
Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,
GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results
Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales